An interventional study of CeraVe® Eczema Soothing Body Wash and Cetaphil® RestoraDerm® Eczema Calming Body Wash in Atopic Dermatitis, sponsored by University of Arizona. Terminated at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-06-04.
Sponsored by University of Arizona · Not applicable, Interventional, and Treatment
This will be a single visit study that will take approximately 2 hours. Up to 50 subjects (up to 25 healthy subjects, and up to 25 subjects with AD) from BUMC dermatology clinics will be enrolled in this study and randomized to receive the 7 cleansers on 7 test spots on their upper extremities. One spot will serve as a control and not receive any cleanser. Each spot will be cleansed with the corresponding cleanser for 15 seconds then rinsed off with tap water. Skin barrier will be measured at baseline, immediately after, 30, 60 and 90 minutes after rinse off.
Up to 50 subjects (up to 25 with healthy skin or 25 with atopic dermatitis) meeting the inclusion criteria will be enrolled in this study. A physical exam will be performed to ensure the subjects have healthy skin versus atopic dermatitis. For atopic dermatitis subjects, AD severity will be graded by the EASI score. Site randomization will be performed to determine which cleansers will be used for each of the 8 test sites (one site will be randomized to act as a control and not receive any cleanser). Baseline skin barrier function (TEWL, pH and hydration) will be measured. Then 1ml of each cleansers will be applied to the corresponding test sites, 2ml of tap water will be added, and lathered in a circular motion for 15 seconds. The sites will then be rinsed off with tap water for 15 seconds. Arms will be padded dry. Barrier functions will be measured again immediately after padding dry, and at 30, 60 and 90 minutes after.
1,435 studies on the registry are indexed under Dermatitis; 131 are open to participants now.
This study's enrollment of 20 is below the median of 64 across 1,131 interventional studies indexed under Dermatitis.
Browse Dermatitis studies →University of Arizona is the lead sponsor of 466 studies on the registry; 87 are open to participants now.
Of its 47 completed or terminated interventional studies of FDA-regulated products, 29 (62%) have results posted.
Counted across the registry records on this site, refreshed daily.
Male and female, at least 18 years of age Subject must be able to comprehend and read the English language. Healthy skin without concurrent atopic dermatitis or diagnosed with atopic dermatitis by a dermatologist
Exclusion Criteria:
Subjects who do not fit the inclusion criteria. Subjects unable to or unwilling to comply with the study procedures Concurrently have other inflammatory skin conditions. Prior known allergy to any components to of the cleansers tested A subject who, in the opinion of the investigator, will be uncooperative or unable to comply with study procedures.
Subject unable to speak or read the English language, since all consents and instructions will be provided in English.
Those that are prisoners or cognitively impaired
One of the 7 forearm locations will be selected to receive CeraVe® Eczema Soothing Body Wash one time only.
Other: CeraVe® Eczema Soothing Body Wash
One of the 7 forearm locations will be selected to receive Cetaphil® RestoraDerm® Eczema Calming Body Wash one time only.
Other: Cetaphil® RestoraDerm® Eczema Calming Body Wash
One of the 7 forearm locations will be selected to receive Dove® Sensitive Skin Body Wash one time only.
Other: Dove® Sensitive Skin Body Wash
One of the 7 forearm locations will be selected to receive Eucerin® Skin Calming Body Wash one time only.
Other: Eucerin® Skin Calming Body Wash
One of the 7 forearm locations will be selected to receive Aveeno® Skin Relief Body Wash one time only.
Other: Aveeno® Skin Relief Body Wash
One of the 7 forearm locations will be selected to receive MooGoo® Milk Wash one time only.
Other: MooGoo® Milk Wash
One of the 7 forearm locations will be selected to receive Free \& Clear Liquid Cleanser
Other: Free & Clear Liquid Cleanser
One of the 7 arm locations will be selected to receive CeraVe® Eczema Soothing Body Wash
One of the 7 arm locations will be selected to receive Cetaphil® RestoraDerm® Eczema Calming Body Wash
One of the 7 arm locations will be selected to receive Dove® Sensitive Skin Body Wash
One of the 7 arm locations will be selected to receive Eucerin® Skin Calming Body Wash
One of the 7 arm locations will be selected to receive Aveeno® Skin Relief Body Wash
One of the 7 arm locations will be selected to receive MooGoo® Milk Wash
One of the 7 arm locations will be selected to receive Free \& Clear Liquid Cleanser
Skin barrier function
Transepidermal water loss (TEWL) will be measured using hand-held, noninvasive skin barrier measuring device (VapoMeter).
Time frame: 2 hours
Skin barrier function
Stratum corneum hydration status will be measured using hand-held, noninvasive skin barrier measuring device (MoistureMeterSC).
Time frame: 2 hours
Skin pH
Skin pH will be measured.
Time frame: 2 hours
Plan to share: No
No publications or documents are linked to this record.
This study is terminated, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Arizona